CONMED CORPORATION Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
CONMED CORPORATION (CNMD) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 0 shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2026-02-17
- CONMED CORPORATION incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2024-09-30 was 0.00 shares.
- CONMED CORPORATION incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2024-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- CONMED CORPORATION incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2023-09-30 was 0.00 shares.
- CONMED CORPORATION incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2023-06-30 was 45.00K shares.
- CONMED CORPORATION incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2025 was 0.00 shares.
- CONMED CORPORATION incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2024 was 0.00 shares, a 100.00% decline from fiscal 2023.
- CONMED CORPORATION incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2023 was 11.00K shares.
- CONMED CORPORATION incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2022 was 0.00 shares, a 100.00% decline from fiscal 2021.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | 0.00 shares 10-K · filed 2026-02-17 | ||||
| 2024-12-31 | 0.00 shares 10-K · filed 2026-02-17 | ||||
| 2024-09-30 | 0.00 shares 10-Q · filed 2024-10-31 | 0.00 shares 10-Q · filed 2024-10-31 | |||
| 2024-06-30 | 0.00 shares 10-Q · filed 2024-08-01 | 0.00 shares 10-Q · filed 2024-08-01 | |||
| 2023-12-31 | 11.00K shares 10-K · filed 2026-02-17 | ||||
| 2023-09-30 | 0.00 shares 10-Q · filed 2024-10-31 | 15.00K shares 10-Q · filed 2024-10-31 | |||
| 2023-06-30 | 45.00K shares 10-Q · filed 2024-08-01 | 22.00K shares 10-Q · filed 2024-08-01 | |||
| 2023-03-31 | 0.00 shares 10-Q · filed 2023-04-27 | ||||
| 2022-12-31 | 0.00 shares 10-K · filed 2025-02-18 | ||||
| 2022-09-30 | 0.00 shares 10-Q · filed 2022-10-27 | 0.00 shares 10-Q · filed 2023-10-26 | |||
| 2022-06-30 | 0.00 shares 10-Q · filed 2023-07-27 | 0.00 shares 10-Q · filed 2023-07-27 | |||
| 2022-03-31 | 684.00K shares 10-Q · filed 2023-04-27 | ||||
| 2021-12-31 | 506.00K shares 10-K · filed 2024-02-28 | ||||
| 2021-09-30 | 468.00K shares 10-Q · filed 2022-10-27 | 427.00K shares 10-Q · filed 2022-10-27 | |||
| 2021-06-30 | 620.00K shares 10-Q · filed 2022-07-28 | 411.00K shares 10-Q · filed 2022-07-28 | |||
| 2021-03-31 | 170.00K shares 10-Q · filed 2022-05-05 | 200.00K shares 10-Q · filed 2021-04-29 | |||
| 2020-12-31 | 0.00 shares 10-K · filed 2023-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |